Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population

Table 3

Adverse events during single-dosed esomeprazole- and pantoprazole-based triple therapies.

Adverse events	EAC group (n = 208)	PAC group (n = 244)	P value
Diarrhea	7 (3.4%)	10 (4.1%)	.131
Constipation	1 (0.5%)	2 (0.8%)	1.000
Abdominal pain	3 (1.4%)	9 (3.7%)	.241
Anorexia	1 (0.5%)	3 (1.2%)	.633
Nausea	7 (3.4%)	8 (3.3%)	1.000
Vomiting	1 (0.5%)	4 (1.6%)	.388
Skin rash	0 (0%)	5 (2%)	.069
Dizziness	12 (5.8%)	11 (4.5%)	.519
Headache	2 (1%)	8 (3.3%)	.196
Taste perversion	32 (15.4%)	29 (11.9%)	.209
Fatigue	10 (4.8%)	6 (2.5%)	.198